• A Case of Large Vessel Giant Cell Arteritis Presenting With Cough and Diagnosed Using an FDG-PET Scan
• A Case of Microscopic Polyangiitis and Giant Cell Arteritis Presenting With Unilateral Visual Loss
• A case of polymyalgia rheumatica complicated with giant thoracic aortic aneurysm with massive intraluminal thrombosis
• Amyloidosis with optic perineuritis masquerading as giant cell arteritis
• Annular elastolytic giant cell granuloma associated with autoimmune hepatitis: Response to ciclosporin
• Antiplatelet therapy to prevent ischemic events in giant cell arteritis: protocol for a systematic review and meta-analysis
• Aortitis
• Application of the 2022 ACR/EULAR criteria for Takayasu arteritis to previously diagnosed patients based on the 1990 ACR criteria
• Artérite à cellules géantes : échodoppler des artères temporales avant biopsie
• Assessment of social deprivation and socioeconomic factors in patients with giant cell arteritis
• Association of clinical, imaging and laboratory parameters with adverse effects of glucocorticoid therapy in patients with giant cell arteritis
• Before Symptomatic Internal Carotid Artery Stenoses can be Attributed to Giant Cell Arteritis, Other Causes must be Ruled Out
• Bilateral juvenile temporal arteritis: a case-based review
• Bing-Neel Syndrome: An Unknown GCA Mimicker
• Case report: "Giant cell arteritis" diagnosed with genital system involvement
• Chinese expert consensus on off-label use of Tocilizumab in rheumatic diseases
• Clinical characteristics and courses of Korean patients with giant cell arteritis: a multi-center retrospective study
• Clinical Features of Aortitis with Gastrointestinal Involvement
• Clinical Manifestations and Prognosis of Giant Cell Arteritis: A Retrospective Cohort Study
• Correction to: Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
• Cryptococcal prostatitis in an immunocompromised patient with tocilizumab and glucocorticoid therapy: A case report
• Current evidence on the role of fibroblasts in large-vessel vasculitides: From pathogenesis to therapeutics
• Current management of giant cell arteritis and its complications
• Diagnosing vasculitis with ultrasound: findings and pitfalls
• Diagnosis of giant cell arteritis by 18F-FDG PET/CT in patients on glucocorticoid therapy: importance of delayed imaging
• Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica
• Doppler ultrasound in giant cell arteritis: More lights than shadows
• Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature
• Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
• Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis
• Evaluation of the extracranial "multifocal arcuate sign," a novel MRI finding for the diagnosis of giant cell arteritis, on STIR and contrast-enhanced T1-weighted images
• Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
• FDA-Approved Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) Inhibitors for Managing Rheumatoid Arthritis: A Narrative Review of the Literature
• Genetics of vasculitis
• Giant cell arteritis and therapeutic response: a dual facet of immunotherapy in metastatic clear cell renal carcinoma
• Giant Cell Arteritis With Bilateral Central Retinal Artery Occlusion and Tongue Necrosis
• Giant Cell Arteritis with Intracranial and Extracranial Aneurysms: A Case Report and Brief Review of the Literature
• Giant Cell Arteritis With Sepsis-Like Symptoms in an Elderly Man: A Case Report
• Giant cell temporal arteritis: a clinicopathological study with emphasis on unnecessary biopsy
• Giant cells in temporal artery biopsies and the risk of large vessel involvement in patients with giant cell arteritis
• Helminth derivative tuftsin-phopshorylcholine, to treat autoimmunity
• High-frequency ultrasound with superb microvascular imaging: a potential tool for ultrasound assessment in patients with giant cell arteritis
• Ibuprofen Would Be the First-Line Nonsteroidal Anti-inflammatory Drug for Polymyalgia Rheumatica: A Case Series of Five Patients
• Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis
• Identifying Giant Cell Arteritis patients with higher risk of relapse and vascular events: a cluster analysis
• IgG4-related periarteritis in the superficial temporal artery, clinically mimicking giant cell arthritis
• Imaging findings in Giant Cell Arteritis: Don't Turn A Blind Eye To The Obvious!
• Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis
• Increased interest with the introduction of fast-track diagnostic pathway is associated with the regionally increased frequency of giant cell arteritis in Poland: a study based on POLVAS registry data
• Inflammatory causes of stroke-Diagnostics and treatment
• Integrating point of care ultrasound into rheumatology practice
• Interpreting Histopathology Reports of Temporal Artery Biopsies Positive for Giant Cell Arteritis (GCA): A Single-Center Retrospective Study
• Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development
• Large vessel vasculitis is a risk factor for relapse only in giant cell arteritis patients without polymyalgia rheumatica
• Large-vessel imaging in patients with giant cell arteritis with scalp involvement: A commentary on giant cell arteritis associated with scalp, tongue or lip necrosis in a French multi-center case control study
• Low incidence of late-onset giant cell arteritis during the first year in patients with polymyalgia rheumatica-a repeated imaging study
• Magnetic resonance imaging to monitor disease activity in giant cell arteritis treated with ultra-short glucocorticoids and tocilizumab
• New-onset of giant cell arteritis with ischemic optic neuropathy following the seventh-dose of COVID-19 mRNA vaccination: A case report and literature review
• Optic Nerve Sheath Measurement on Ultrasound: A Novel Diagnostic Test for Giant Cell Arteritis
• Optic nerve sheath measurement to monitor disease activity in giant cell arteritis: a pilot study
• Optical frequency domain imaging (OFDI) represents a novel technique for the diagnosis of giant cell arteritis
• Outcome and prognosis of isolated carotid vasculitis
• Plasma proteome profiling in giant cell arteritis
• Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms
• Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study
• Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue
• Polymyalgia rheumatica: What's new?
• Positron Emission Tomography/Computed Tomography in Polymyalgia Rheumatica: When and for What-A Critical Review
• Predictive Factors for Biopsy-Negative Giant Cell Arteritis and Alternative Diagnoses in a Neuro-Ophthalmology Context
• Recommendations for defining giant cell arteritis fast-track clinics. English version
• Relapses in giant cell arteritis: Updated review for clinical practice
• Role and potential of ¹⁸F-fluorodeoxyglucose-positron emission tomography-computed tomography in large-vessel vasculitis: a comprehensive review
• Self-limited giant cell arteritis: The dilemma associated with its diagnosis and treatment
• Serum leukemia inhibitory factor (LIF) levels in patients with Takayasu's and Giant cell arteritis: A cross-sectional study
• Signal Regulatory Protein α Expression in Systemic Vasculitis
• Single-cell transcriptomic analysis to identify endomembrane regulation of metalloproteins and motor proteins in autoimmunity
• Squamous cell carcinoma: A malignant mimicker of giant cell arteritis
• Subclinical Aortic Inflammation in Patients with Polymyalgia Rheumatica
• Subclinical Giant Cell Arteritis in Polymyalgia Rheumatica: Is Vascular Imaging Really Ready to Determine Steroid Dosing?
• Submacular and Intraretinal Fluid Associated with Arteritic Anterior Ischemic Optic Neuropathy
• Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center
• Teaching NeuroImage: Giant Cell Arteritis With Optic Perineuritis
• The Common Carotid Artery in the Ultrasound Evaluation of Giant Cell Arteritis
• The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumatica
• The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials
• The spectrum of giant cell arteritis through a rheumatology lens
• The Spectrum of Isolated Retinal Artery Occlusion Secondary to Giant Cell Arteritis
• The utility of (18)F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis: A systematic review and meta-analysis
• The utility of (18)F-FDG-PET/CT in detecting extracranial large vessel vasculitis in rheumatic polymyalgia or giant cell arteritis. A systematic review and meta-analysis
• The value of axillary, facial, occipital, subclavian and common carotid arteries ultrasound in the diagnosis of giant cell arteritis
• Thrombosis in vasculitis: An updated review of etiology, pathophysiology, and treatment
• Tocilizumab use in giant cell arteritis: comparing Pharmaceutical Benefits Scheme eligible and ineligible cases in South Australia
• Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study
• Ultrasonography of the superficial temporal and axillary arteries in giant cell arteritis diagnosis
• Ultrasound Examination of Common Carotid Adventitial Thickness Can Differentiate Takayasu Arteritis and Large Vessel Giant Cell Arteritis
• Unclear cause of unilateral blindness with normal inflammation parameters
• Updates in the Management of Giant Cell Arteritis
• Upper respiratory tract and orofacial manifestations of new-onset giant cell arteritis: results from a large, prospective inception cohort study
• Vascular ultrasound as a follow-up tool in patients with giant cell arteritis: a prospective observational cohort study
• What Is Polymyalgia Rheumatica?